118 related articles for article (PubMed ID: 38163576)
1. Enhancer of zeste homolog 2 (EZH2)-dependent sirtuin-3 determines sensitivity to glucose starvation in radioresistant head and neck cancer cells.
Chang HW; Park JJ; Lee WH; Kim SH; Lee JC; Nam HY; Kim MR; Han MW; Lee YS; Kim SY; Kim SW
Cell Signal; 2024 Mar; 115():111029. PubMed ID: 38163576
[TBL] [Abstract][Full Text] [Related]
2. p53-dependent glutamine usage determines susceptibility to oxidative stress in radioresistant head and neck cancer cells.
Chang HW; Lee M; Lee YS; Kim SH; Lee JC; Park JJ; Nam HY; Kim MR; Han MW; Kim SW; Kim SY
Cell Signal; 2021 Jan; 77():109820. PubMed ID: 33137455
[TBL] [Abstract][Full Text] [Related]
3. EPHA3 Contributes to Epigenetic Suppression of PTEN in Radioresistant Head and Neck Cancer.
Kim SH; Kang BC; Seong D; Lee WH; An JH; Je HU; Cha HJ; Chang HW; Kim SY; Kim SW; Han MW
Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33919657
[TBL] [Abstract][Full Text] [Related]
4. Minnelide/Triptolide Impairs Mitochondrial Function by Regulating SIRT3 in P53-Dependent Manner in Non-Small Cell Lung Cancer.
Kumar A; Corey C; Scott I; Shiva S; D'Cunha J
PLoS One; 2016; 11(8):e0160783. PubMed ID: 27501149
[TBL] [Abstract][Full Text] [Related]
5. SIRT3 deregulation is linked to mitochondrial dysfunction in Alzheimer's disease.
Lee J; Kim Y; Liu T; Hwang YJ; Hyeon SJ; Im H; Lee K; Alvarez VE; McKee AC; Um SJ; Hur M; Mook-Jung I; Kowall NW; Ryu H
Aging Cell; 2018 Feb; 17(1):. PubMed ID: 29130578
[TBL] [Abstract][Full Text] [Related]
6. LncRNA LINC00673 inhibits p53 expression by interacting with EZH2 and DNMT1 in papillary thyroid carcinoma.
Meng XF; Zhao LY; Chu XF
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2075-2083. PubMed ID: 30915752
[TBL] [Abstract][Full Text] [Related]
7. Sirtuin 3 Mediated by Spinal cMyc-Enhancer of Zeste Homology 2 Pathway Plays an Important Role in Human Immunodeficiency Virus-Related Neuropathic Pain Model.
Zhu X; Yi H; Gu J; Liu S; Hayashi K; Ikegami D; Pardo M; Toborek M; Roy S; Li H; Levitt RC; Hao S
Anesth Analg; 2024 Mar; ():. PubMed ID: 38446700
[TBL] [Abstract][Full Text] [Related]
8. SIRT3 deficiency exacerbates p53/Parkin‑mediated mitophagy inhibition and promotes mitochondrial dysfunction: Implication for aged hearts.
Li Y; Ma Y; Song L; Yu L; Zhang L; Zhang Y; Xing Y; Yin Y; Ma H
Int J Mol Med; 2018 Jun; 41(6):3517-3526. PubMed ID: 29532856
[TBL] [Abstract][Full Text] [Related]
9. Tumor-suppressive function of EZH2 is through inhibiting glutaminase.
Liu Y; Tu CE; Guo X; Wu C; Gu C; Lai Q; Fang Y; Huang J; Wang Z; Li A; Liu S
Cell Death Dis; 2021 Oct; 12(11):975. PubMed ID: 34671029
[TBL] [Abstract][Full Text] [Related]
10. Enhancer of zeste homolog 2 is overexpressed and contributes to epigenetic inactivation of p21 and phosphatase and tensin homolog in B-cell acute lymphoblastic leukemia.
Chen J; Li J; Han Q; Sun Z; Wang J; Wang S; Zhao RC
Exp Biol Med (Maywood); 2012 Sep; 237(9):1110-6. PubMed ID: 22956625
[TBL] [Abstract][Full Text] [Related]
11. TET1 exerts its tumor suppressor function by interacting with p53-EZH2 pathway in gastric cancer.
Fu HL; Ma Y; Lu LG; Hou P; Li BJ; Jin WL; Cui DX
J Biomed Nanotechnol; 2014 Jul; 10(7):1217-30. PubMed ID: 24804542
[TBL] [Abstract][Full Text] [Related]
12. An immunohistochemical panel of insulin-like growth factor II mRNA-binding protein 3 (IMP3), enhancer of zeste homolog 2 (EZH2), and p53 is useful for a diagnosis in bile duct biopsy.
Sasaki M; Sato Y
Virchows Arch; 2021 Oct; 479(4):697-703. PubMed ID: 34115196
[TBL] [Abstract][Full Text] [Related]
13. Sirtuin 3 induces apoptosis and necroptosis by regulating mutant p53 expression in small‑cell lung cancer.
Tang X; Li Y; Liu L; Guo R; Zhang P; Zhang Y; Zhang Y; Zhao J; Su J; Sun L; Liu Y
Oncol Rep; 2020 Feb; 43(2):591-600. PubMed ID: 31894331
[TBL] [Abstract][Full Text] [Related]
14. LINC01116 promotes proliferation, invasion and migration of osteosarcoma cells by silencing p53 and EZH2.
Zhang ZF; Xu HH; Hu WH; Hu TY; Wang XB
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6813-6823. PubMed ID: 31486480
[TBL] [Abstract][Full Text] [Related]
15. P53 suppresses the progression of hepatocellular carcinoma via miR-15a by decreasing OGT expression and EZH2 stabilization.
You Z; Peng D; Cao Y; Zhu Y; Yin J; Zhang G; Peng X
J Cell Mol Med; 2021 Oct; 25(19):9168-9182. PubMed ID: 34510715
[TBL] [Abstract][Full Text] [Related]
16. EZH2 Expression in Intestinal Neuroendocrine Tumors.
Faviana P; Marconcini R; Ricci S; Galli L; Lippolis P; Farci F; Castagna M; Boldrini L
Appl Immunohistochem Mol Morphol; 2019 Oct; 27(9):689-693. PubMed ID: 29489508
[TBL] [Abstract][Full Text] [Related]
17. The Histone Methyltransferase Enzyme Enhancer of Zeste Homolog 2 Protects against Podocyte Oxidative Stress and Renal Injury in Diabetes.
Siddiqi FS; Majumder S; Thai K; Abdalla M; Hu P; Advani SL; White KE; Bowskill BB; Guarna G; Dos Santos CC; Connelly KA; Advani A
J Am Soc Nephrol; 2016 Jul; 27(7):2021-34. PubMed ID: 26534922
[TBL] [Abstract][Full Text] [Related]
18. An EZH2-mediated epigenetic mechanism behind p53-dependent tissue sensitivity to DNA damage.
Kuser-Abali G; Gong L; Yan J; Liu Q; Zeng W; Williamson A; Lim CB; Molloy ME; Little JB; Huang L; Yuan ZM
Proc Natl Acad Sci U S A; 2018 Mar; 115(13):3452-3457. PubMed ID: 29540569
[TBL] [Abstract][Full Text] [Related]
19. SIRT3 deacetylates and promotes degradation of P53 in PTEN-defective non-small cell lung cancer.
Xiong Y; Wang L; Wang S; Wang M; Zhao J; Zhang Z; Li X; Jia L; Han Y
J Cancer Res Clin Oncol; 2018 Feb; 144(2):189-198. PubMed ID: 29103158
[TBL] [Abstract][Full Text] [Related]
20. Expression and clinical implications of enhancer of Zeste homolog 2 and p53 protein in squamous cell carcinoma and precancerous lesions in the cervix.
Zhang HM; Chen SQ; Yao SZ
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
